코오롱티슈진
14,760KRWMarket close of 10/27 (Tue)
Up +0.27%+40KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)14,600KRWDown -1.08%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 14,870
- High
- 15,230
- Low
- 14,210
- Day range
- Day range low 14,210 high 15,230, open 14,870, close 14,760, previous close 14,720
- Volume
- 21×10K shares
- 3.2B KRW 0.40× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
2%2% of the way up from the lowest close in 1 year (252 sessions) · -89.4% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedOutside financial data coverage, so not verified
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range+0.27%+0.27%, 0.1× the usual (20-session average ±3.91%)That day +0.27% · usual ±3.91% · large-move threshold ±7.8%
The other 2 are within the usual range
- Trading value0.4×usual range
- Foreign & institutional+500.00 million KRWusual range
See the full check report
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.